News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
253,165 Results
Type
Article (11021)
Company Profile (43)
Press Release (242101)
Section
Business (68920)
Career Advice (300)
Deals (13118)
Drug Delivery (51)
Drug Development (15159)
Employer Resources (51)
FDA (6994)
Job Trends (6461)
News (108709)
Policy (12467)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (2)
2024 Bio NC Digital (1)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (1)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
Academia (904)
Accelerated approval (1)
Adcomms (4)
Allergies (35)
Alliances (18918)
ALS (14)
Alzheimer's disease (366)
Antibody-drug conjugate (ADC) (21)
Approvals (7057)
Artificial intelligence (157)
Autoimmune disease (5)
Automation (5)
Bankruptcy (87)
Best Places to Work (5648)
BIOSECURE Act (4)
Biosimilars (54)
Biotechnology (21)
Bladder cancer (21)
Brain cancer (4)
Breast cancer (90)
Cancer (575)
Cardiovascular disease (66)
Career advice (282)
Career pathing (2)
CAR-T (22)
Cell therapy (93)
Cervical cancer (7)
Clinical research (12770)
Collaboration (308)
Compensation (30)
Complete response letters (2)
COVID-19 (915)
CRISPR (12)
C-suite (100)
Cystic fibrosis (19)
Data (661)
Decentralized trials (1)
Denatured (11)
Depression (12)
Diabetes (96)
Diagnostics (3562)
Digital health (12)
Diversity (4)
Diversity, equity & inclusion (13)
Drug discovery (37)
Drug pricing (55)
Drug shortages (10)
Duchenne muscular dystrophy (30)
Earnings (22944)
Editorial (16)
Employer branding (6)
Employer resources (45)
Events (51693)
Executive appointments (310)
FDA (7517)
Featured Employer (10)
Frontotemporal dementia (3)
Funding (274)
Gene editing (27)
Generative AI (17)
Gene therapy (80)
GLP-1 (226)
Government (2333)
Grass and pollen (2)
Guidances (31)
Healthcare (9796)
Huntington's disease (2)
IgA nephropathy (11)
Immunology and inflammation (21)
Indications (13)
Infectious disease (969)
Inflammatory bowel disease (41)
Inflation Reduction Act (6)
Influenza (15)
Intellectual property (24)
Interviews (24)
IPO (5144)
IRA (19)
Job creations (1047)
Job search strategy (263)
Kidney cancer (1)
Labor market (3)
Layoffs (114)
Legal (2716)
Liver cancer (17)
Lung cancer (82)
Lymphoma (38)
Machine learning (2)
Management (18)
Manufacturing (86)
MASH (25)
Medical device (6847)
Medtech (6849)
Mergers & acquisitions (8242)
Metabolic disorders (265)
Multiple sclerosis (35)
NASH (8)
Neurodegenerative disease (21)
Neuropsychiatric disorders (6)
Neuroscience (495)
NextGen: Class of 2025 (3476)
Non-profit (1782)
Northern California (833)
Now hiring (3)
Obesity (146)
Opinion (91)
Ovarian cancer (15)
Pain (22)
Pancreatic cancer (12)
Parkinson's disease (23)
Partnered (10)
Patents (50)
Patient recruitment (31)
Peanut (23)
People (22232)
Pharmaceutical (14)
Pharmacy benefit managers (12)
Phase I (2916)
Phase II (4594)
Phase III (5837)
Pipeline (390)
Podcasts (26)
Policy (48)
Postmarket research (906)
Preclinical (978)
Press Release (15)
Prostate cancer (38)
Psychedelics (11)
Radiopharmaceuticals (81)
Rare diseases (108)
Real estate (1794)
Recruiting (19)
Regulatory (8289)
Reports (19)
Research institute (765)
Resumes & cover letters (26)
Rett syndrome (3)
RNA editing (2)
RSV (17)
Schizophrenia (18)
Series A (43)
Series B (39)
Service/supplier (3)
Sickle cell disease (25)
Southern California (697)
Special edition (7)
Spinal muscular atrophy (37)
Sponsored (8)
Startups (1476)
Stomach cancer (2)
Supply chain (26)
The Weekly (15)
United States (8213)
Vaccines (202)
Venture capitalists (17)
Webinars (6)
Weight loss (87)
Women's health (20)
Worklife (3)
Date
Today (54)
Last 7 days (289)
Last 30 days (1061)
Last 365 days (13187)
2025 (3604)
2024 (13433)
2023 (14729)
2022 (22673)
2021 (24460)
2020 (24422)
2019 (21898)
2018 (16371)
2017 (10886)
2016 (11628)
2015 (13592)
2014 (10043)
2013 (8352)
2012 (8890)
2011 (8995)
2010 (7280)
Location
Africa (309)
Alabama (13)
Alaska (2)
Arizona (78)
Arkansas (6)
Asia (12882)
Australia (1867)
California (1889)
Canada (677)
China (171)
Colorado (122)
Connecticut (89)
Delaware (49)
Europe (32411)
Florida (333)
Georgia (95)
Hawaii (1)
Idaho (26)
Illinois (235)
India (18)
Indiana (140)
Iowa (1)
Japan (76)
Kansas (24)
Kentucky (13)
Louisiana (6)
Maine (26)
Maryland (412)
Massachusetts (1456)
Michigan (94)
Minnesota (134)
Mississippi (2)
Missouri (57)
Montana (6)
Nebraska (14)
Nevada (18)
New Hampshire (25)
New Jersey (703)
New Mexico (9)
New York (639)
North Carolina (432)
North Dakota (1)
Northern California (833)
Ohio (67)
Oklahoma (6)
Oregon (12)
Pennsylvania (528)
Puerto Rico (3)
Rhode Island (8)
South America (466)
South Carolina (8)
Southern California (697)
Tennessee (69)
Texas (263)
Utah (99)
Virginia (39)
Washington D.C. (27)
Washington State (173)
West Virginia (3)
Wisconsin (25)
253,165 Results for "glaxosmithkline consumer healthcare".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Healthcare
As Sanofi Preps Consumer Healthcare Sale, Here’s a Look Back at Similar High-Profile Deals
Sanofi looks to follow a deep history of Big Pharma offloading their consumer healthcare businesses.
October 16, 2024
·
6 min read
·
Annalee Armstrong
Deals
Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit
Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French government taking a stake as well to ensure the business remains in the county.
October 21, 2024
·
2 min read
·
Annalee Armstrong
Press Releases
Therma Bright Secures an Initial Limited Exclusive U.S. Marketing and Distribution Contract for Its Consumer Products with Global Wellness Products LLC
National Distributor to Sell Cold Sore Prevention Device Through National Ecommerce Sales Through Direct to Consumer Marketing Efforts
March 13, 2025
·
4 min read
Press Releases
Optum Rx Further Simplifies Consumer Access to Prescription Drugs
March 19, 2025
·
2 min read
Press Releases
Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
October 21, 2024
·
11 min read
Business
Lilly, Pfizer Take Meds Straight To Consumers in Renewed DTC Push
Big Pharma has finally gotten its arms around something advocates have wanted for a long time: direct-to-consumer sales. Eli Lilly and Pfizer are leading the way.
September 4, 2024
·
5 min read
·
Annalee Armstrong
Press Releases
BioHarvest Sciences to Present at WeBull Consumer Stocks Webinar on February 18
February 12, 2025
·
3 min read
Press Releases
CVS Health announces Pharmacy and Consumer Wellness leadership appointments
December 3, 2024
·
3 min read
Pharm Country
First PFAS “Forever Chemicals” Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com
Quest Diagnostics, the world’s leader in diagnostic information services, announced the availability of the first consumer-initiated, physician-ordered blood-draw test for PFAS chemicals with the option to confer over the phone with a physician about the results.
February 12, 2024
·
8 min read
Press Releases
Targeted Genomics Receives FDA Clearance for First Direct-to-Consumer Celiac Disease Genetic Health Risk Test
February 17, 2025
·
2 min read
1 of 25,317
Next
